Ongoing variation in vaccine schedule implementation requires pharmacists and clinicians to collaborate closely, reinforce evidence-based care, and monitor vulnerable populations for gaps in immunization coverage.
In an interview with Pharmacy Times, Lora Sparkman, MSN, RN, vice president of patient safety and quality at Relias, addressed ongoing challenges in implementing new childhood vaccine guidelines and their implications for clinicians and pharmacists. Sparkman emphasized the critical importance of adhering to research and evidence-based practice, even as shared decision-making frameworks are introduced. While shared decision-making can enhance patient engagement, she stressed that it does not change the underlying science of safe and effective immunization.
“It's really going to be important for health systems to make sure there's enough oversight and keep their finger on the pulse of vulnerabilities, using science and evidence-based practice.” - Lora Sparkman, MSN, RN
Sparkman highlighted particular concern for vulnerable populations, such as those served by Medicaid programs. Social determinants of health and systemic disparities make these patients more fragile, and any misalignment among payers, health systems, and clinicians can increase risk to patient safety and quality of care. She noted that while associations like the American Academy of Pediatrics and the American Medical Association are actively monitoring the situation and providing guidance, variation in implementation continues to pose challenges.
For pharmacists, these developments underscore the need for vigilance and education. Sparkman emphasized the importance of ensuring that providers—who may not all be active in professional associations—receive consistent updates and training on evolving immunization guidance. Pharmacists, working alongside clinicians, can play a critical role in reinforcing evidence-based practices, supporting patient education, and identifying gaps in care that may arise from inconsistencies in schedule implementation.
Sparkman’s insights underscore the continued need for interprofessional collaboration and proactive engagement to maintain high standards of patient safety and immunization coverage amid evolving policy and practice shifts.
Previous coverage from Sparkman can be found
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
